Nonhuman primate models in translational regenerative medicine

Stem Cells and Development

Volumn 23, Issue , 2014, Pages 83-87

  Daadi, Marcel M ^a   Barberi, Tiziano ^a   Shi, Qiang ^a   Lanford, Robert E ^a  

^a SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; NEUROPROTECTIVE AGENT;

ARTICLE; CELL TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL MODEL; IMMUNE RESPONSE; MEDICAL RESEARCH; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSLATIONAL RESEARCH; ANIMAL; ANIMAL MODEL; CYTOLOGY; FINANCIAL MANAGEMENT; HUMAN; PRIMATE; PROCEDURES; PROGRAM DEVELOPMENT; STEM CELL RESEARCH; TRENDS; UNITED STATES;

ANIMALIA; PRIMATES; RODENTIA;

ANIMALS; CELL TRANSPLANTATION; FINANCING, GOVERNMENT; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, ANIMAL; PRIMATES; PROGRAM DEVELOPMENT; REGENERATIVE MEDICINE; STEM CELL RESEARCH; TEXAS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84919338035     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0374     Document Type: Article

References (29)

1. Davis GC, AC Williams, SP Markey, MH Ebert, ED Caine, et al. (1979). Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249-254.
2. Langston JW, P Ballard, JW Tetrud and I Irwin. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
3. Bergman H, A Raz, A Feingold, A Nini, I Nelken, et al. (1998). Physiology of MPTP tremor. Mov Disord 13 Suppl 3: 29-34.
4. Bedard PJ, T Di Paolo, P Falardeau and R Boucher. (1986). Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding. Brain Res 379:294-299.
5. Purisai MG AL McCormack WJ Langston, LC Johnston and DA Di Monte. (2005). Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 20: 898-906.
6. Schneider JS and CJ Kovelowski 2nd (1990). Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res 519:122-128.
7. Emborg ME, Y Liu, J Xi, X Zhang, Y Yin, et al. (2013). Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep 3:646-650.
8. Daadi MM, BA Grueter, RC Malenka, DE Redmond Jr. and GK Steinberg. (2012). Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS ONE 7: e41120.
9. Takagi Y, J Takahashi, H Saiki, A Morizane, T Hayashi, et al. (2005). Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115: 102-109.
10. Kriks S, JW Shim, J Piao, YM Ganat, DR Wakeman, et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480:547-551.
11. Morizane A, D Doi, T Kikuchi, K Okita, A Hotta, et al. (2013). Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a nonhuman primate. Stem Cell Rep 1:283-292.
12. Doi D, A Morizane, T Kikuchi, H Onoe, T Hayashi, et al. (2012). Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells 30:935-945.
13. Emborg ME, Z Zhang, V Joers, K Brunner, V Bondarenko, et al. (2013). Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant 22:831-838.
14. Kefalopoulou Z, M Politis, P Piccini, N Mencacci, K Bhatia, et al. (2013). Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol. 71:83-87.
15. Mendez I, A Vinuela, A Astradsson, K Mukhida, P Hallett, et al. (2008). Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 14:507-509.
16. STAIR. (1999). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30:2752-2758.
17. Marshall JW and RM Ridley. (2003). Assessment of cognitive and motor deficits in a marmoset model of stroke. Ilar J 44:153-160.
18. Freret T, V Bouet, J Toutain, R Saulnier, P Pro-Sistiaga, et al. (2008). Intraluminal thread model of focal stroke in the non-human primate. J Cereb Blood Flow Metab 28:786-796.
19. Fukuda S and GJ del Zoppo. (2003). Models of focal cerebral ischemia in the nonhuman primate. Ilar J 44:96-104.
20. Nudo RJ, D Larson, EJ Plautz, KM Friel, S Barbay, et al. (2003). A squirrel monkey model of poststroke motor recovery. Ilar J 44:161-174.
21. Huang J, J Mocco, TF Choudhri, A Poisik, SJ Popilskis, et al. (2000). A modified transorbital baboon model of reperfused stroke. Stroke 31:3054-3063.
22. Kuge Y, C Yokota, M Tagaya, Y Hasegawa, A Nishimura, et al. (2001). Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke. J Cereb Blood Flow Metab 21:202-210.
23. Virley D, SJ Hadingham, JC Roberts, B Farnfield, H Elliott, et al. (2004). A new primate model of focal stroke: endothelin-1-induced middle cerebral artery occlusion and reperfusion in the common marmoset. J Cereb Blood Flow Metab 24:24-41.
24. Bahjat FR, RL Williams-Karnesky, SG Kohama, GA West, KP Doyle, et al. (2011). Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. J Cereb Blood Flow Metab 31:1229-1242.
25. Cook DJ, L Teves and M Tymianski. (2012). Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483:213-217.
26. Roitberg BZ, E Mangubat, EY Chen, K Sugaya, KR Thulborn, et al. (2006). Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J Neurosurg 105:96-102.
27. Borchin B, J Chen and T Barberi. (2013). Derivation and FACS-mediated purification of PA X3+/PA X7+ skeletal muscle precursors from human pluripotent stem cells. Stem Cell Rep 1:620-631.
28. Mengarelli I and T Barberi. (2013). Derivation of multiple cranial tissues and isolation of lens epithelium-like cells from human embryonic stem cells. Stem Cells Transl Med 2:94-106.
29. Shi Q, G Schatten, V Hodara, C Simerly and JL VandeBerg. (2013). Endothelial reconstitution by CD34 + progenitors derived from baboon embryonic stem cells. J Cell Mol Med 17: 242-251.